Clinical Trials Browser

Phase 1 × tandutinib × Other hematologic neoplasm × Clear all

NCT00064584 2009-03-24

Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML)

Phase 1 Completed

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00274248 2008-02-11

MLN518 in Combination With Standard Induction Chemo. for Treatment of Patients With Newly Diagnosed Acute Myelogenous Leukemia

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute